Sort
23,748 grants matching “melanoma”
Structure, mechanism, and pharmacology of BRAF and its partners in the RAS/RAF/MAP kinase pathway
$1,014,601Michael J Eck · Dana-Farber Cancer Inst · R35 · FY2024 · CA
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
$1,014,535James A Decaprio · Dana-Farber Cancer Inst · R35 · FY2023 · CA
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
$1,014,535James A Decaprio · Dana-Farber Cancer Inst · R35 · FY2022 · CA
Keratinocyte Stem Cells and Cancer Stem Cells in Non-Melanoma Skin Cancer
$1,014,494Jonathan Vogel · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Reprogramming of T cells for the Treatment of Melanoma
$1,014,415Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2012 · CA
Role of progenitor exhausted CD8 T cells and the progenitor niche in anti-PD1 efficacy
$1,014,151Alexander Huang · University Of Pennsylvania · R01 · FY2025 · CA
NIA Confocal Imaging Facility
$1,013,467Fred Indig · National Institute On Aging · ZIC · FY2018 · AG
Induction of an Antitumor Immune Response in Patients with Melanoma
$1,013,259Patrick Hwu · University Of Tx Md Anderson Can Ctr · P50 · FY2010 · CA
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
$1,012,470Suresh Ambudkar · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Preclinical development of AlaTIMP-2 as an cancer therapeutic
$1,012,438William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Genetic Epidemiology of Cancer
$1,011,986Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2020 · HG
Nanosystems Biology Cancer Center
$1,009,425James R. Heath · California Institute Of Technology · U54 · FY2017 · CA
Postmortem Pathology
$1,008,987David E Kleiner · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Genetically Engineered Mouse Models to Study RTK Function in Melanoma
$1,008,827Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response
$1,008,673Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression
$1,008,673Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Functional genomic analysis of neural crest development
$1,008,325William J Pavan · National Human Genome Research Institute · ZIA · FY2020 · HG
Analysis of Dominant Megacolon: Another Hirschsprung Disease Model
$1,008,325William J Pavan · National Human Genome Research Institute · ZIA · FY2020 · HG
MELANOMA RESEARCH PROGRAM TEAM SCIENCE AWARD
$1,008,313Regents Of The University Of California, San Francisco, The · · FY2025 · Defense Health Agency
Genetic Epidemiology of Lung Cancer
$1,006,509Marshall W Anderson · University Of Cincinnati · U01 · FY2008 · CA
Predevelopment of VV2003, a Novel CRAC Channel Inhibitor, to Improve Outcomes Associated with Checkpoint Inhibitor Immunotherapy
$1,004,278Milton L Greenberg · Vivreon Biosciences, Llc · R44 · FY2019 · CA
ANALYSIS OF DOMINANT MEGACOLON--ANOTHER MODEL FORHIRSCHSPRUNG DISEASE
$1,004,214William J Pavan · National Human Genome Research Institute · ZIA · FY2009 · HG
Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases
$1,003,255Chi-Chao Chan · National Eye Institute · ZIA · FY2012 · EY
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,002,000Ze'ev A Ronai · Cedars-Sinai Medical Center · R35 · FY2025 · CA
Development of a small molecule activator of integrin cell adhesion to enhance therapeutic responses to checkpoint blockade in cancer
$1,001,898Upendra Marathi · 7 Hills Pharma, Llc · R42 · FY2019 · CA